-
1
-
-
33750864910
-
Extensively drug- resistant tuberculosis (XDR-TB): Recommendations for prevention and control
-
World Health Organization
-
World Health Organization. Extensively drug- resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006;81:430-2.
-
(2006)
Wkly Epidemiol Rec
, vol.81
, pp. 430-432
-
-
-
2
-
-
33645119729
-
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugsworldwide
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugsworldwide. MMWR Morb Mortal Wkly Rep 2006; 55:301-5.
-
(2006)
MMWR Morb Mortal Wkly Rep
, vol.55
, pp. 301-305
-
-
-
3
-
-
33847699798
-
125 years after Robert Koch's discovery of the tubercle bacillus-the new XDR-TB threat: Is "science" enough to tackle the epidemic?
-
Migliori GB, Loddenkemper R, Blasi F, Ra- viglione MC. 125 years after Robert Koch's discovery of the tubercle bacillus-the new XDR-TB threat: is "science" enough to tackle the epidemic? Eur Respir J 2007; 29:423-7.
-
(2007)
Eur Respir J
, vol.29
, pp. 423-427
-
-
Migliori, G.B.1
Loddenkemper, R.2
Blasi, F.3
Ra- viglione, M.C.4
-
4
-
-
34247857498
-
Extensively drug-resistant tuberculosis, Italy and Germany
-
Migliori GB, Ortmann J, Girardi E, et al. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis 2007; 13:780-1.
-
(2007)
Emerg Infect Dis
, vol.13
, pp. 780-781
-
-
Migliori, G.B.1
Ortmann, J.2
Girardi, E.3
-
5
-
-
63849276723
-
Epidemiology and clinical management of XDR- TB: A systematic review by TBNET
-
Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR- TB: a systematic review by TBNET. Eur Respir J 2009;33:871-81.
-
(2009)
Eur Respir J
, vol.33
, pp. 871-881
-
-
Sotgiu, G.1
Ferrara, G.2
Matteelli, A.3
-
6
-
-
67651143836
-
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in MDR-TB
-
Epub ahead of print
-
Migliori GB, Eker B, Richardson MD, et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in MDR-TB. Eur Respir J 2009 [Epub ahead of print].
-
(2009)
Eur Respir J
-
-
Migliori, G.B.1
Eker, B.2
Richardson, M.D.3
-
7
-
-
55549142208
-
Mul-tidrug- and extensively-drug resistant tuberculosis: A TBNET survey in Germany
-
Eker B, Ortmann J, Migliori GB, et al. Mul-tidrug- and extensively-drug resistant tuberculosis: a TBNET survey in Germany. Emerg Infect Dis 2008; 14:1700-6.
-
(2008)
Emerg Infect Dis
, vol.14
, pp. 1700-1706
-
-
Eker, B.1
Ortmann, J.2
Migliori, G.B.3
-
8
-
-
49249098575
-
Comprehensive treatment of extensively drug-resistant tuberculosis
-
Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008;359: 563-74.
-
(2008)
N Engl J Med
, vol.359
, pp. 563-574
-
-
Mitnick, C.D.1
Shin, S.S.2
Seung, K.J.3
-
9
-
-
60549100405
-
Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB
-
Chan ED, Strand MJ, Iseman MD. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB. Clin Infect Dis 2009; 48:e50-2.
-
(2009)
Clin Infect Dis
, vol.48
-
-
Chan, E.D.1
Strand, M.J.2
Iseman, M.D.3
-
10
-
-
36849040101
-
Clinical and operational value of the extensively drug-resistant tuberculosi definition
-
Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosi definition. Eur Respir J 2007; 30:623-6.
-
(2007)
Eur Respir J
, vol.30
, pp. 623-626
-
-
Migliori, G.B.1
Besozzi, G.2
Girardi, E.3
-
11
-
-
40749118083
-
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: Different methodology and settings, same results
-
Migliori GB, Lange C, Girardi E, et al. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Clin Infect Dis 2008; 46:958-9.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 958-959
-
-
Migliori, G.B.1
Lange, C.2
Girardi, E.3
-
12
-
-
42949120597
-
Fluo- roquinolones: Are they essential to treat multi- drug-resistant tuberculosis?
-
Migliori GB, Lange C, Girardi E, et al. Fluo- roquinolones: are they essential to treat multi- drug-resistant tuberculosis? Eur Respir J 2008; 31:904-10.
-
(2008)
Eur Respir J
, vol.31
, pp. 904-910
-
-
Migliori, G.B.1
Lange, C.2
Girardi, E.3
-
13
-
-
49649128410
-
Resistance to second-line injectables and treatment outcomes in MDR and XDR-TB cases
-
Migliori GB, Lange C, Centis R, et al. Resistance to second-line injectables and treatment outcomes in MDR and XDR-TB cases. Eur Respir J 2008;31:1155-9.
-
(2008)
Eur Respir J
, vol.31
, pp. 1155-1159
-
-
Migliori, G.B.1
Lange, C.2
Centis, R.3
-
15
-
-
57349181603
-
Of blind men and elephants: Making sense ofex- tensively drug-resistant tuberculosis
-
Migliori GB, Richardson MD, Lange C. Of blind men and elephants: making sense ofex- tensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008; 178:1000-1.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 1000-1001
-
-
Migliori, G.B.1
Richardson, M.D.2
Lange, C.3
|